drugset / Trial / NCT06209879
Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid Arthritis
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to evaluate the efficacy of hydroxypropyl guar-and hyaluronic acid containing lubricant eye drops in rheumatoid arthritis patients . The main question it aims to answer is: • whether adding hydroxypropyl guar-and hyaluronic acid containing lubricant eye drops to steroid-based dry eye therapy improves dry eye symptoms in rheumatoid arthritis patients after 1 month. Participants with rheumatoid arthritis will be treat with SYSTANE™ Hydration Lubricant Eye Drops (1-2 drops 4 times a day) and 0.1% Fluorometholone (1-2 drops 3 times a day) in both eyes for 12 weeks
Timeline
- Start
- 2024-02-05
- Primary completion
- 2024-12
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYSTANE™ Hydration Lubricant Eye Drops | Unknown | 0.15 % | Topical |
| Subject | SYSTANE™ Hydration Lubricant Eye Drops | Unknown | 0.3 % | Topical |
| Subject | SYSTANE™ Hydration Lubricant Eye Drops | Unknown | 0.4 % | Topical |
| Background | 0.1% FML | Unknown | 0.1 % | Topical |